These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33592037)

  • 1. The impact of information about different absolute benefits and harms on intention to participate in colorectal cancer screening: A think-aloud study and online randomised experiment.
    Usher-Smith JA; Mills KM; Riedinger C; Saunders CL; Helsingen LM; Lytvyn L; Buskermolen M; Lansdorp-Vogelaar I; Bretthauer M; Guyatt G; Griffin SJ
    PLoS One; 2021; 16(2):e0246991. PubMed ID: 33592037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline.
    Helsingen LM; Vandvik PO; Jodal HC; Agoritsas T; Lytvyn L; Anderson JC; Auer R; Murphy SB; Almadi MA; Corley DA; Quinlan C; Fuchs JM; McKinnon A; Qaseem A; Heen AF; Siemieniuk RAC; Kalager M; Usher-Smith JA; Lansdorp-Vogelaar I; Bretthauer M; Guyatt G
    BMJ; 2019 Oct; 367():l5515. PubMed ID: 31578196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the Preferences and Considerations of the Public Towards Risk-Stratified Screening for Colorectal Cancer: Insights From Think-Aloud Interviews Based on a Discrete Choice Experiment.
    Dennison RA; Clune RJ; Morris S; Thomas C; Usher-Smith JA
    Health Expect; 2024 Aug; 27(4):e14153. PubMed ID: 39030943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
    Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
    Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study.
    Buskermolen M; Cenin DR; Helsingen LM; Guyatt G; Vandvik PO; Haug U; Bretthauer M; Lansdorp-Vogelaar I
    BMJ; 2019 Oct; 367():l5383. PubMed ID: 31578177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for colorectal cancer using the faecal occult blood test, Hemoccult.
    Hewitson P; Glasziou P; Irwig L; Towler B; Watson E
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001216. PubMed ID: 17253456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of personalised risk information compared to a positive/negative result on informed choice and intention to undergo colonoscopy following colorectal Cancer screening in Scotland (PERICCS) - a randomised controlled trial: study protocol.
    Steele RJC; Digby J; Chambers JA; O'Carroll RE
    BMC Public Health; 2019 Apr; 19(1):411. PubMed ID: 30991987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are anxiety levels associated with the decision to participate in a Swedish colorectal cancer screening programme? A nationwide cross-sectional study.
    Wangmar J; von Vogelsang AC; Hultcrantz R; Fritzell K; Wengström Y; Jervaeus A
    BMJ Open; 2018 Dec; 8(12):e025109. PubMed ID: 30580275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
    Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
    Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
    JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of numerical information on intention to participate in cervical screening among women offered HPV vaccination: a randomised study.
    Hestbech MS; Gyrd-Hansen D; Kragstrup J; Siersma V; Brodersen J
    Scand J Prim Health Care; 2016 Dec; 34(4):401-419. PubMed ID: 27845597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with intentions to adhere to colorectal cancer screening follow-up exams.
    Zheng YF; Saito T; Takahashi M; Ishibashi T; Kai I
    BMC Public Health; 2006 Nov; 6():272. PubMed ID: 17083746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR.
    Hoffmann S; Crispin A; Lindoerfer D; Sroczynski G; Siebert U; Mansmann U; Consortium F
    BMC Gastroenterol; 2020 May; 20(1):131. PubMed ID: 32370777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived Importance of the Benefits and Harms of Colorectal Cancer Screening: A Best-Worst Scaling Study.
    Pluymen LPM; Yebyo HG; Stegeman I; Fransen MP; Dekker E; Brabers AEM; Leeflang MMG
    Value Health; 2023 Jun; 26(6):918-924. PubMed ID: 36646279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lin JS; Perdue LA; Henrikson NB; Bean SI; Blasi PR
    JAMA; 2021 May; 325(19):1978-1998. PubMed ID: 34003220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
    Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
    Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey mode and asking about future intentions did not impact self-reported colorectal cancer screening accuracy.
    Beebe TJ; Ziegenfuss JY; Jenkins SM; Lackore KA; Johnson TP
    BMC Med Res Methodol; 2014 Feb; 14():19. PubMed ID: 24499399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a hypothetical scenario to assess public preferences for colorectal surveillance following screening-detected, intermediate-risk adenomas: annual home-based stool test vs. triennial colonoscopy.
    Bonello B; Ghanouni A; Bowyer HL; MacRae E; Atkin W; Halloran SP; Wardle J; von Wagner C
    BMC Gastroenterol; 2016 Sep; 16(1):113. PubMed ID: 27618798
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.